358 related articles for article (PubMed ID: 30236451)
1. Cholangiopathies - Towards a molecular understanding.
Tam PKH; Yiu RS; Lendahl U; Andersson ER
EBioMedicine; 2018 Sep; 35():381-393. PubMed ID: 30236451
[TBL] [Abstract][Full Text] [Related]
2. The Cholangiopathies.
Lazaridis KN; LaRusso NF
Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
[TBL] [Abstract][Full Text] [Related]
4. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.
Sato K; Glaser S; Kennedy L; Liangpunsakul S; Meng F; Francis H; Alpini G
Expert Opin Ther Targets; 2019 Jun; 23(6):461-472. PubMed ID: 30990740
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids and Biliary Fibrosis.
Aseem SO; Hylemon PB; Zhou H
Cells; 2023 Mar; 12(5):. PubMed ID: 36899928
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
Trussoni CE; O'Hara SP; LaRusso NF
Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
8. Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.
Luo Z; Jegga AG; Bezerra JA
Hepatology; 2018 Feb; 67(2):676-689. PubMed ID: 28865156
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.
Esparza-Baquer A; Labiano I; Bujanda L; Perugorria MJ; Banales JM
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):15-27. PubMed ID: 26774196
[TBL] [Abstract][Full Text] [Related]
10. Cellular senescence in the cholangiopathies.
Bogert PS; O'Hara SP; LaRusso NF
Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
[TBL] [Abstract][Full Text] [Related]
11. Animal models of cholestasis: An update on inflammatory cholangiopathies.
Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies.
Salas-Silva S; Simoni-Nieves A; Lopez-Ramirez J; Bucio L; Gómez-Quiroz LE; Gutiérrez-Ruiz MC; Roma MG
Life Sci; 2019 Feb; 218():324-339. PubMed ID: 30610870
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic-induced liver injury and fibrosis.
Österreicher CH; Trauner M
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
[TBL] [Abstract][Full Text] [Related]
15. Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.
Soroka CJ; Assis DN; Boyer JL
Methods Mol Biol; 2019; 1981():363-372. PubMed ID: 31016667
[TBL] [Abstract][Full Text] [Related]
16. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
17. The pathobiology of biliary epithelia.
Alpini G; McGill JM; Larusso NF
Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.
Trauner M; Halilbasic E; Kazemi-Shirazi L; Kienbacher C; Staufer K; Traussnigg S; Hofer H
Dig Dis; 2014; 32(5):631-6. PubMed ID: 25034298
[TBL] [Abstract][Full Text] [Related]
19. Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.
Pollheimer MJ; Fickert P
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):207-17. PubMed ID: 25172178
[TBL] [Abstract][Full Text] [Related]
20. New insights into autoimmune cholangitis through animal models.
Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
